tribulus and Diabetes-Mellitus--Type-2

tribulus has been researched along with Diabetes-Mellitus--Type-2* in 3 studies

Trials

1 trial(s) available for tribulus and Diabetes-Mellitus--Type-2

ArticleYear
Efficacy of the Hydroalcoholic Extract of Tribulus terrestris on the Serum Glucose and Lipid Profile of Women With Diabetes Mellitus: A Double-Blind Randomized Placebo-Controlled Clinical Trial.
    Journal of evidence-based complementary & alternative medicine, 2016, Volume: 21, Issue:4

    Considering traditional use of Tribulus terrestris in diabetes and proven antihyperglycemic and antihyperlipidemic effects of T terrestris in animal studies, we aimed to evaluate the efficacy of the hydroalcoholic extract of T terrestris on the serum glucose and lipid profile of women with non-insulin-dependent diabetes mellitus.. Ninety-eight women with diabetes mellitus type 2 were randomly allocated to receive the T terrestris (1000 mg/d) or placebo for 3 months. The patients were evaluated in terms of the fasting blood glucose, 2-hour postprandial glucose, glycosylated hemoglobin, and lipid profile.. Tribulus terrestris showed a significant blood glucose-lowering effect in diabetic women compared to placebo (P < .05). Also, the total cholesterol and low-density lipoprotein of T terrestris group was significantly reduced compared with placebo, while no significant effect was observed in the triglyceride and high-density lipoprotein levels.. The study showed preliminary promising hypoglycemic effect of T terrestris in women with diabetes mellitus type 2.

    Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lipids; Middle Aged; Plant Extracts; Tribulus

2016

Other Studies

2 other study(ies) available for tribulus and Diabetes-Mellitus--Type-2

ArticleYear
Ligand-targeted fishing of α-glucosidase inhibitors from Tribulus terrestris L. based on chitosan-functionalized multi-walled carbon nanotubes with immobilized α-glucosidase.
    Analytical and bioanalytical chemistry, 2023, Volume: 415, Issue:14

    α-Glucosidase inhibitors in natural products are one of the promising drugs for the treatment of type 2 diabetes. However, due to the complexity of the matrix, it is challenging to comprehensibly clarify the specific pharmacodynamic substances. In this study, a novel high-throughput inhibitor screening strategy was established based on covalent binding of α-glucosidase on chitosan-functionalized multi-walled carbon nanotubes coupled with high-resolution mass spectrometry. The synthesized MWCNTs@CS@GA@α-Glu was characterized by TEM, SEM, FTIR, Raman, and TG. Performance studies showed that the microreactor exhibited stronger thermostability and pH tolerance than that of the free one while maintaining its inherent catalytic activity. Feasibility study applying a model mixture of known α-glucosidase ligand and non-ligands indicated the selectivity and specificity of the system. By integrating ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-QTOF-MS) with ion mobility mass spectrometry (IMS), 15 ligands were obtained and tentatively identified from Tribulus terrestris L., including 8 steroidal saponins, 4 flavonoids, and 3 alkaloids. These inhibitors were further validated by in vivo experiments and molecular docking simulation.

    Topics: alpha-Glucosidases; Chitosan; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Molecular Docking Simulation; Nanotubes, Carbon; Plant Extracts; Tribulus

2023
The Obscure Effect of
    International journal of molecular sciences, 2021, Aug-12, Volume: 22, Issue:16

    Diabetes is a predictor of nonalcoholic fatty liver disease (NAFLD). There are data suggesting that

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Fatty Acids; Fatty Liver; Inulin; Liver; Male; Rats; Rats, Sprague-Dawley; Saponins; Streptozocin; Treatment Outcome; Tribulus

2021